REGN is now in the
S&P 500

Regeneron is a science-driven large capitalization biotechnology company. Learn more here.

Meet Evans W., featured in
the Annual Report
2012 Annual Report [PDF]

Attend

Attend the Annual Meeting of Shareholders June 14, 2013.
See Upcoming Events, below, for details.

View all releases Recent Press Releases
May 21, 2013 Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 15, 2013 Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 8, 2013 Regeneron Announces Upcoming 2013 Investor Conference Presentations


Upcoming Events
May 29, 2013
8:40 AM ET		 38th Annual dbAccess Healthcare Conference
Jun 3, 2013
9:00 AM ET		 Webcast Jefferies 2013 Healthcare Conference
Jun 11, 2013
11:40 AM ET		 Goldman Sachs 34th Annual Global Healthcare Conference
Jun 14, 2013
10:30 AM ET		 Regeneron Annual Shareholders Meeting
Westchester Marriott Hotel
670 White Plains Road
Tarrytown, NY 10591
view map


View all events & presentations Recent Events


Short Cuts


Close Video
Close Window
Close Window
Close
Form content here please :)